• No results found

Manfred Lutz Ramírez

N/A
N/A
Protected

Academic year: 2021

Share "Manfred Lutz Ramírez"

Copied!
5
0
0

Loading.... (view fulltext now)

Full text

(1)

Manfred Lutz Ramírez

ƒProfession: physician

Personal information

ƒEmails: [email protected] y @g [email protected]

ƒResidence: Costa Rica

• Health Economics Master, Universitat Pompeu Fabra, Barcelona, Spain (currently)

Di it l i ti (Fl h Ph t h D t ) 2009

Academic studies

• Digital animation (Flash, Photoshop, Dreamweaver, etc), 2009. • Medical speciality in Homeopathy, Instituto Politécnico Nacional de

México, 2008.

• Professional Doctor in medicine and surgery, Universidad de Ciencias Médicas (UCIMED), 2003

• Bachelor´s degree in medicine and surgery, Universidad de Ciencias Médicas (UCIMED), 2002

• General Certificate of Education, Saint Francis College, 1996 • Primary studies approved, Anglo American School, 1991y pp , g ,

Languages

• Spanish (100%) • English (100%)

(2)

• Internship, 2002

- Surgery, Hospital San Juan de Dios ( Jan-Feb-Mar )

Job experience

g y ( )

- Pediatrics, Hospital Nacional de Niños ( Apr-May-Jun ) - Gynecology, Hospital Max Peralta ( Jul-Aug-Sep )

- Internal medicine, Hospital Calderón Guardia ( Oct-Nov-Dec ) • Centro Médico Nuestra Señora

- June -October, 2003

- Providing general medicine services, as well as managing my own office.Providing general medicine services, as well as managing my own office. • Centro Médico LAIN

- November, 2003 – March, 2004

- Providing medical services as well as nutrition follow ups for patients. • Private medical office in San José and Atenas

- November 2003 – March 2006 - November, 2003 – March, 2006

- Providing general medicine services as well as managing my own office. • Asunción Clinic

- March 2006 – December, 2007

- Providing general medicine and homeopathy services as well as managing my own office.

• Agent at Hewlett Packard

- July 2006 – January 2007: Account Sales Representative

- February, 2007 – March 2008: Resource help desk/Parts Identification agent. • Pfizer Central America and the Caribbean.

- April, 2008 – March, 2009 - Clinical Research Associate - Outcomes Research Physician - March, 2009 – December 2009

- Outcomes Research Physician - Medical Quality Compliance Managery p g - Product Compliance Quality Officer - Product Physician

- January 2010 – January 2011 - Outcomes Research Lead - Product Physician

- January 2011 - current day

(3)

• Founder and president of ISPOR Chapter Central America and the Caribbean (CAC) - July 2011 – current day

Several meetings and workshops given throughout the region to decision makers - Several meetings and workshops given throughout the region to decision makers

and physicians

- Organized and led the 1stISPOR CAC Chapter Meeting, November 2012

• Cost-effectiveness of Varenicline versus all interventions available for quitting smoking in the adult population of Costa Rica using the BENESCO model.Acta méd. costarric. Vol 52 (4), octubre-diciembre 2010

Publications

( ),

• Cost analysis of Varenicline vs Nicotine Replacement Therapy and unaided cessation in Nicaragua (ISPOR International meeting 2011)

• Cost-utility analysis of Varenicline vs existing smoking cessation strategies in Panama (ISPOR International meeting 2011)(Finalist Green Ribbon)

• Cost-effectiveness of Varenicline vs existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model (ISPOR International meeting 2011)

• Cost-effectiveness analysis of anti-pneumococcal vaccines vs no vaccination in El Salvador. (ISPOR Latin America meeting, 2011)

• Cost-effectiveness analysis of etanercept vs available anti-TNF and IL-6 blockers for treating rheumatoid arthritis in Guatemala. (ISPOR Latin America meeting, 2011) (Finalist Green Ribbon)

• Cost-effectiveness of varenicline vs existing smoking cessation strategies in Dominican Republic using the BENESCO model. (ISPOR Latin America meeting, 2011)(Finalist Green Ribb )

Ribbon)

• Cost-utility analysis of varenicline vs existing smoking cessation strategies in El Salvador (ISPOR Europuean meeting, 2011)

• Cost-effectiveness analysis of anti-pneumococcal vaccines in Panamá (ISPOR Europuean meeting, 2011)

• Cost-effectiveness analysis of anti-pneumococcal vaccines in Guatemala (ISPOR Europuean meeting, 2011)

(4)

• Cost-effectiveness analysis of voriconazole, amphotericine B and caspofungin for invasive aspergilosis patients in Panamá (ISPOR Europuean meeting, 2011)

• Cost-effectiveness analysis of linezolid vs vancomycin for ventilator-associated pneumonia patients in Panamá (ISPOR Europuean meeting, 2011)

• Cost-Effectiveness Analysis of Varenicline Versus Existing Smoking Cessation Strategies in Central America and the Caribbean Using the BENESCO ModelHospital Practice, Feb issue, 2012

• Cost Analysis of Varenicline Versus Bupropion, Nicotine Replacement Therapy, and Unaided Cessation in Nicaragua” Hospital Practice, Feb issue, 2012

• Economic analysis of voriconazole, amphotericine B and caspofungin for invasive aspergilosis patients in private hospitals in Dominican Republic (ISPOR International Meeting, 2012)

• Cost-effectiveness analysis of voriconazole, amphotericine B and caspofungin for invasive aspergilosis patients in public hospitals in Dominican Republic (ISPOR International Meeting, 2012) • Economic analysis of linezolid vs vancomycin for ventilator-associated pneumonia patients inEconomic analysis of linezolid vs vancomycin for ventilator associated pneumonia patients in private hospitals in Dominican Republic (ISPOR International Meeting, 2012)

• Cost-effectiveness analysis of linezolid vs vancomycin for ventilator-associated pneumonia patients in the Dominican Republic public case (accepted for ISPOR International Meeting, 2012) • Economic evaluation of apixaban for atrial fibrillation in Costa Rica. (submitted to ISPOR International Meeting 2013)

International Meeting, 2013)

• Economic evaluation of apixaban for venous thromboembolism in total knee and total hip replacement in Guatemala (submitted to ISPOR International Meeting, 2013)

• Cost-effectiveness analysis of etanercept vs availabe anti-TNF and IL-6 blockers for treating rheumatoid arthritis in Costa Rica (submitted to ISPOR International Meeting, 2013)

• Cost-effectiveness analysis of etanercept vs availabe anti-TNF and IL-6 blockers for treating rheumatoid arthritis in Honduras (submitted to ISPOR International Meeting, 2013)

• Cost-effectiveness analysis of etanercept vs availabe anti-TNF and IL-6 blockers for treating rheumatoid arthritis in El Salvador (submitted to ISPOR International Meeting, 2013)

• Economic evaluation of linezolid vs vancomycin for ventilator-associated pneumonia patients in Guatemala (submitted to ISPOR International Meeting, 2013)

• A cost-effectiveness analysis of linezolid vs vancomycin for ventilator-associated pneumonia patients in Honduras (submitted to ISPOR International Meeting, 2013)

(5)

• XIX Course of Pediatrics Actualization, 2001 XXI C f P di t i A t li ti 2003

Courses

• XXI Course of Pediatrics Actualization, 2003 • CPR course, 2003

• Course of Microsoft Excel and Power Point, 2003 ( I also know how to work with Microsoft Word and Internet )

• Course of professional ethics and responsibility for physicians, 2003 • Cholesterol at the Present Day, 2003

• Flash, Dreamworks, Fireworks, 2008-2009 • CRA certificate, 2008

• GCP course, 2008

• Introduction to Modeling, ISPOR Latin America Meeting, 2009 • Applied Modeling, ISPOR Latin America Meeting, 2009

• Statistical Methods for Pharmacoeconomics & Outcomes Research, ISPOR International Meeting, 2011

• Introduction to Patient-Reported Outcomes, ISPOR International Meeting, 2011 • Utility Measures, ISPOR International Meeting, 2011

• Budget Impact Analysis, ISPOR Latin America Meeting, 2011 • Applied Modeling, ISPOR Latin America Meeting, 2011

• Extracting cost data for economic analysis in Latin America, ISPOR Latin America Meeting, 2011

• Transferability of Cost-Effectiveness Data between Countries, ISPOR European Meeting, 20110

• Elements of Pharmaceutical/Biotech Pricing I – Introduction, ISPOR International Meeting, 2012

• Daisy Plus Online Course – Health Economy – Fundación Santa Fe de Colombia - 2012

• Creator and producer of the radio program for children “El Bosque Má

Other activities

• Creator and producer of the radio program for children El Bosque Má-gico del Conocimiento”, used to air on Radio Costa Rica.

• Typing skills: 40 words per minute

• Writer of children stories and books for young adults and adolescence. C t kill

• Computer skills:

References

Related documents

Our preliminary approach with LESS technique was a single-trocar renal biopsy, performed with an operative laparoscope (Karl Storz®) with a 5 mm working channel. This attempt was

Conservation, energy efficiency and renewable energy sources are vital elements in strategies which aim to reduce carbon dioxide emissions.. However, these technical measures run

The purpose of this research is to understand and analyze the effects of training satisfaction, pay satisfaction to employee turnover intention with

the risk of finding a positive Ortolani or Barlow sign at the time of the initial newborn screening.. If this examination is negative, the absolute risk of there being a true

competition has been chosen to determine the competitiveness of banks by the market share of. three, five, or ten

The release profiles showed zero-order release behavior up to 12 hours where the highest drug release was 99.78 % of the sofosbuvir loaded in the chitosan microspheres, indicating

Keywords: Two semiconductor Quantum dots, Optical nano cavity, Cavity Quantum electrodynamics (CQED), Quantum optical non-linearties, Quantum confined Stark effects

circuit held that trade association activities in maintaining a scale of prices based on "cost" as found in a trade survey under a California law similar